Skip to content

PEG ratio at other companies

Royalty Pharma logo
Royalty PharmaRPRX
0.3×
Revvity logo
RevvityRVTY
0.6×
Innoviva, Inc. logo
Innoviva, Inc.INVA
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
0.3×-0.1×
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
0.3×

Other financials

Income statement

See full
Revenue$51.7M+14.1%
Operating income$17.4M+148%
Net income-$13.3M+68.6%
EPS (diluted)-$0.67+69.7%

Balance sheet

See full
Cash & equivalents$115.1M+140%
Total debt$5.1M+14.2%
Total equity$997.3M+25.4%
Total assets$1.5B+69.2%

Cash flow

See full
Operating cash flow$48.7M+291%
CapEx$228.0K+6.5%
Free cash flow$48.5M+289%

Valuation

See full
Market cap$5.71B+96.7%

Profitability

See full
Gross margin91.9%
Operating margin34.5%+23.0pp
Net margin55.9%+35.7pp
FCF margin44.8%+16.8pp

Returns & leverage

See full
Return on equity17.1%+11.5pp
Debt / equity0.0×
Current ratio21.3×+16.0×

Where this comes from

Calculated from Ligand Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The official record: Ligand Pharmaceuticals’s 10-Q, filed November 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ligand Pharmaceuticals's PEG ratio?
Ligand Pharmaceuticals (LGND) reported PEG ratio of 9.6× in Q3 2025.
How has Ligand Pharmaceuticals's PEG ratio changed year-over-year?
Ligand Pharmaceuticals's PEG ratio increased by 4061.3% year-over-year, from 0.2× to 9.6×.
What does PEG ratio mean?
The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.